ArticleJAMA dermatology2025

C-Reactive Protein and Response to Adalimumab in Patients With Hidradenitis Suppurativa: A Post Hoc Analysis of 2 Randomized Clinical Trials.

Simon J Gunter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.